HSIC
Henry Schein Inc
$
71.460
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
71.960
Open
71.960
VWAP
71.51
Vol
2.05M
Mkt Cap
8.93B
Low
71.230
Amount
146.57M
EV/EBITDA(TTM)
12.28
Total Shares
128.05M
EV
13.11B
EV/OCF(TTM)
19.05
P/S(TTM)
0.71
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
3.32B
+4.04%
1.266
+6.38%
3.26B
+2.83%
1.264
+3.62%
3.22B
+2.82%
1.199
-2.5%
Estimates Revision
The market is revising Downward the revenue expectations for Henry Schein, Inc. (HSIC) for FY2025, with the revenue forecasts being adjusted by -0.45% over the past three months. During the same period, the stock price has changed by 8.98%.
Revenue Estimates for FY2025
Revise Downward
-0.45%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.14%
In Past 3 Month
Stock Price
Go Up
+8.98%
In Past 3 Month
8 Analyst Rating
2.95% Upside
Wall Street analysts forecast HSIC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSIC is 73.57 USD with a low forecast of 55.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
4 Hold
1 Sell
Hold
2.95% Upside
Current: 71.460
Low
55.00
Averages
73.57
High
86.00
2.95% Upside
Current: 71.460
Low
55.00
Averages
73.57
High
86.00
Stifel
Buy -> Hold
downgrade
$80 -> $75
2025-07-24
New
Reason
Stifel
Price Target
$80 -> $75
2025-07-24
New
downgrade
Buy -> Hold
Reason
Stifel downgraded Henry Schein to Hold from Buy with a price target of $75, down from $80. The downgrade is predicated on five main concerns, the analyst says, namely that the firm's diligence identifies future U.S. share losses for the company's consumables business; checks suggest the multi-year share shift to online will continue for the foreseeable future; despite these market share concerns, the stock currently trades at a slight premium to its three-year average; the near-term low-hanging fruit may be limited as Henry Schein has already undergone three restructurings in the past five years; and prior industry checks identified risks with the company's biggest customer. The firm added that more recent conversations would assign a slightly higher probability that at least some portion of the Heartland revenue moves to another provider in the coming quarters.
Baird
Outperform
to
Neutral
downgrade
$82 -> $72
2025-07-14
Reason
Baird
Price Target
$82 -> $72
2025-07-14
downgrade
Outperform
to
Neutral
Reason
Baird downgraded Henry Schein to Neutral from Outperform with a price target of $72, down from $82. The firm cites concerns that the company's biggest customer, Heartland Dental, may be looking to transition away from it by year-end for the downgrade. Channel checks suggest Heartland may be considering direct manufacturer consumables and equipment agreements with a non-dental U.S. medical dealer, the analyst tells investors in a research note. Baird thinks such a move could become an added overhang on the stock.
Leerink
Michael Cherny
Market Perform
maintain
$69 -> $75
2025-07-14
Reason
Leerink
Michael Cherny
Price Target
$69 -> $75
2025-07-14
maintain
Market Perform
Reason
Leerink analyst Michael Cherny raised the firm's price target on Henry Schein to $75 from $69 and keeps a Market Perform rating on the shares. Heading into Q2 earnings, the firm is updating dental company estimates and publishing the results of its fourth semi-annual dental survey of 63 dental practitioners in the United States. There is clearly a budding interest in identifying incremental improvements across the dental space, even if each opportunity seems to be company-specific in what remains a still-challenged total dental end-market, Leerink says. The firm sees reasons to be positive on each stock in its coverage but also has some offsetting questions that limit too much constructiveness.
Barrington Research
Michael Petusky
Buy
Maintains
$90
2025-02-26
Reason
Barrington Research
Michael Petusky
Price Target
$90
2025-02-26
Maintains
Buy
Reason
UBS
Kevin Caliendo
Hold
Maintains
$83 → $80
2025-02-26
Reason
UBS
Kevin Caliendo
Price Target
$83 → $80
2025-02-26
Maintains
Hold
Reason
Wells Fargo
Vik Chopra
Hold
Initiates
$80
2025-02-14
Reason
Wells Fargo
Vik Chopra
Price Target
$80
2025-02-14
Initiates
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Henry Schein Inc (HSIC.O) is 14.45, compared to its 5-year average forward P/E of 15.97. For a more detailed relative valuation and DCF analysis to assess Henry Schein Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
15.97
Current PE
14.45
Overvalued PE
17.77
Undervalued PE
14.17
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
11.88
Current EV/EBITDA
11.92
Overvalued EV/EBITDA
12.74
Undervalued EV/EBITDA
11.03
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
0.79
Current PS
0.67
Overvalued PS
0.88
Undervalued PS
0.69
Financials
Annual
Quarterly
FY2025Q1
YoY :
-0.13%
3.17B
Total Revenue
FY2025Q1
YoY :
+12.96%
183.00M
Operating Profit
FY2025Q1
YoY :
+15.79%
110.00M
Net Income after Tax
FY2025Q1
YoY :
+22.22%
0.88
EPS - Diluted
FY2025Q1
YoY :
-104.08%
-6.00M
Free Cash Flow
FY2025Q1
YoY :
-1.23%
29.61
Gross Profit Margin - %
FY2025Q1
YoY :
+7.51%
4.01
FCF Margin - %
FY2025Q1
YoY :
+15.53%
3.57
Net Margin - %
FY2025Q1
YoY :
-2.73%
6.78
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
671.6K
USD
3
6-9
Months
0.0
USD
0
0-12
Months
1.7M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
1.3M
Volume
5
6-9
Months
2.0M
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
1.6M
Volume
Months
6-9
8
6.2M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
32.0K
USD
4
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
1
8.0K
USD
Months
6-9
1
8.0K
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
671.6K
USD
3
6-9
Months
0.0
USD
0
0-12
Months
1.7M
USD
2
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
HSIC News & Events
Events Timeline
2025-07-15 (ET)
2025-07-15
07:08:59
Henry Schein CEO Stanley Bergman to retire
2025-05-05 (ET)
2025-05-05
06:03:14
Henry Schein sees annual run-rate savings at high end of $75M-$100M goal
2025-05-05
06:01:54
Henry Schein backs FY25 adjusted EPS $4.80-$4.94, consensus $4.84
Sign Up For More Events
Sign Up For More Events
News
4.5
07-25NASDAQ.COMS&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
6.0
07-25BenzingaNasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
4.0
07-25BenzingaThis Norfolk Southern Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Sign Up For More News
People Also Watch
KD
Kyndryl Holdings Inc
39.120
USD
+2.11%
WTFC
Wintrust Financial Corp
132.110
USD
-0.52%
BSAC
Banco Santander Chile
23.420
USD
-1.14%
FRT
Federal Realty Investment Trust
94.240
USD
-0.50%
KNX
Knight-Swift Transportation Holdings Inc
44.840
USD
-1.56%
HESM
Hess Midstream LP
40.280
USD
+2.05%
RGEN
Repligen Corp
121.735
USD
-0.11%
CR
Crane Co
190.730
USD
+0.82%
APA
APA Corp (US)
19.100
USD
-1.04%
RGLD
Royal Gold Inc
154.990
USD
-0.37%
FAQ
What is Henry Schein Inc (HSIC) stock price today?
The current price of HSIC is 71.46 USD — it has decreased -1.6 % in the last trading day.
What is Henry Schein Inc (HSIC)'s business?
What is the price predicton of HSIC Stock?
What is Henry Schein Inc (HSIC)'s revenue for the last quarter?
What is Henry Schein Inc (HSIC)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Henry Schein Inc (HSIC)'s fundamentals?
How many employees does Henry Schein Inc (HSIC). have?